# CLIMB BIO INC (CLYM)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CLYM/

- Reporting holders: 1
- Reported value: $9.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $9.4K | 821 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 1 | $9.4K |
| Q2 2026 | 110 | $764.4M |
| Q1 2026 | 80 | $221.8M |
| Q4 2025 | 64 | $157.5M |
| Q3 2025 | 67 | $89.8M |
| Q2 2025 | 69 | $61.9M |
| Q1 2025 | 76 | $63.4M |
| Q4 2024 | 78 | $100.3M |
| Q3 2024 | 70 | $278.2M |
| Q2 2024 | 47 | $354.8M |
| Q1 2024 | 20 | $46.2M |
| Q4 2023 | 22 | $45.5M |